Dr. Pramil Babu Vaghasia, MD

Dr. Vaghasia practices at Ppsc in Bakersfield, California.

Dr. Vaghasia's NPI, 1861798332, was assigned on February 1, 2011. Dr. Vaghasia graduated from Ross University School of Medicine in 2008. Dr. Vaghasia holds California license A137848.

Dr. Vaghasia's primary practice is Ppsc, at 8305 Brimhall Rd, Bakersfield, CA 93312 in Kern County. The practice phone is (661) 695-6777.

Dr. Vaghasia's primary practice is Ppsc in Bakersfield, California. Dr. Vaghasia is also affiliated with Adventist Health Bakersfield. The medical group on file is St. John Critical Care Medical Group, Inc. Dmand AI also links Dr. Vaghasia to 4 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaghasia practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Vaghasia's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Vaghasia is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Vaghasia's licenses on file in 3 states: California, Minnesota and Virginia.

Dmand AI lists acute respiratory failure, aneurysm, asthma, atrial fibrillation and flutter, bronchitis, chronic anemia, chronic diabetes and chronic hypertension among the conditions Dr. Vaghasia treats.

CMS data shows 4,216 Medicare services from Dr. Vaghasia across 20 procedure codes in 2024, for 1,069 Medicare patients. Medicare paid $365,152 for them.

CMS counts 1,069 Medicare patients who saw Dr. Vaghasia in 2024. The largest group is 65 to 74, with 449 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaghasia's median patient age at 60, with 59% women.

In 2024, Dr. Vaghasia wrote 5,400 Medicare Part D claims for 742 patients. CMS names the drug for 5,185 of them, across 45 drugs with 11 or more claims each, at $1,812,111 in total drug cost. In 2023, CMS named 4,121 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Vaghasia for performance year 2024, reported as part of a group. Dr. Vaghasia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vaghasia as offering telehealth.

Dmand AI links 5 papers to Dr. Vaghasia, published from 2013 to 2019. 2013 was the busiest year, with 2. Dr. Vaghasia's most frequent co-authors are Ruchi Bansal, MD, Praveen Reddy Bondalapati, MD and Peter Mclaren Black, MD, PhD.

CMS Open Payments shows 377 general payments to Dr. Vaghasia from 40 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. GlaxoSmithKline, LLC. paid the most, $2,239.

Dr. Vaghasia graduated from Ross University School of Medicine in 2008.

Dr. Vaghasia is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.